Apontis Pharma AG Strategic Asset Allocation Index
Apontis Pharma AG strategic asset allocation index. Apontis Pharma AG (APPH) has a Strategic Asset Allocation Index of 0.1% as of June 2023. Strategic assets (PP&E of €37.35K plus long-term investments of €-) total €37.35K, measured against net assets of €38.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Apontis Pharma AG (APPH) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Apontis Pharma AG (2019–2021)
Strategic asset allocation index of Apontis Pharma AG from 2019 to 2021. This chart shows how Apontis Pharma AG's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2021. As of June 2023, the index stands at 0.1%, representing strategic assets of €37.35K against net assets of €38.04 Million EUR. Check APPH tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Apontis Pharma AG Strategic Asset Allocation Index by Year (2019–2021)
Apontis Pharma AG strategic asset allocation index by year from 2019 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Apontis Pharma AG from 2019 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Apontis Pharma AG (APPH) total market value.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.0% | €18.68K | €18.68K | €- | €40.71 Million | ▼ -1.1 pp |
| 2020 | 1.2% | €41.12K | €41.12K | €- | €3.46 Million | ▼ -0.3 pp |
| 2019 | 1.5% | €67.50K | €67.50K | €- | €4.64 Million | — |